Publication of Shareholder Circular

RNS Number : 6870Q
Omega Diagnostics Group PLC
22 June 2020
 

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Publication of Shareholder Circular

 

Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and COVID-19 testing, confirms that the Circular to Shareholders in respect of the Fundraising, announced on 19 June 2020, is now available on the Company's website here:

http://www.omegadiagnostics.com/Investor-Relations/Corporate-Information  

 

 

 

Contacts: 

 

Omega Diagnostics Group PLC 

Tel: 01259 763 030

Bill Rhodes, Interim Non-Executive Chairman

Colin King, Chief Executive 

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director




finnCap Ltd  

Tel: 020 7220 0500

Geoff Nash/Hannah Boros (Corporate Finance)


Camille Gochez (ECM)




Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CIRXLLFLBQLFBBF
UK 100